Clinical Trial Update: Assess Cancer in Ovarian Tumors With Biomarkers. [NA]

View source ↗

Summary

A biomarker-based clinical trial assessing cancer in ovarian tumors sponsored by Ciphergen Biosystems has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Ciphergen Biosystems | Conditions: Ovarian Tumor | NA | Status: COMPLETED